AIM ImmunoTech Inc. announced a stock dividend of one share for every 1,000 outstanding shares and options/warrants. Record date is January 9, 2026, distribution date is January 13, 2026. Fractional shares will be rounded down with remaining fractions paid in cash at $1.305 per share. Stockholders don’t need to take action, EQ will administer the dividend. The Company focuses on developing therapeutics for cancers, immune disorders, and viral diseases, including COVID-19, with lead product Ampligen® (rintatolimod). Forward-looking statements caution about risks and uncertainties related to Ampligen’s approval. Contact JTC Team, LLC for more information.

Read more at Barchart: AIM ImmunoTech Announces Stock Dividend